Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BAUSCH HEALTH COMPANIES INC.

(BHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Bausch Health Brief: Says FDA Approves Bausch + Lomb Device For Use In Ophthalmic Surgery

04/07/2021 | 07:33am EDT


ę MT Newswires 2021
All news about BAUSCH HEALTH COMPANIES INC.
06/15INSIDER TRENDS : Bausch Health Companies Insider Sale Scales Back 90-Days of Buy..
MT
06/08BAUSCH HEALTHá : ANNOUNCES EARLY TENDER RESULTS AND EARLY SETTLEMENT DATE FOR CA..
PU
06/08BAUSCH HEALTH COMPANIES INC.á : Entry into a Material Definitive Agreement, Crea..
AQ
06/08BAUSCH HEALTHá : + Lomb, Lochan to Develop Next-Generation of Clinical Decision ..
MT
06/08BAUSCH HEALTH BRIEF : Bausch + Lomb and Lochan Enter Into Agreement to Develop t..
MT
06/03BAUSCH HEALTHá : And Clearside Biomedical Announce U.S. FDA Filing Acceptance Fo..
AQ
06/03BAUSCH HEALTHá : + lomb and clearside biomedical announce u.s. fda filing accept..
AQ
06/02BAUSCH HEALTHá : And Clearside Biomedical Announce U.S. FDA Filing Acceptance Fo..
MT
06/02BAUSCH HEALTHá : Clearside Biomedical's Resubmission of Xipere Application Accep..
MT
06/02BAUSCH HEALTH BRIEF : Bausch Health And Clearside Biomedical Announce U.S. FDA F..
MT
More news
Financials (USD)
Sales 2021 8 611 M - -
Net income 2021 -719 M - -
Net Debt 2021 21 594 M - -
P/E ratio 2021 -15,2x
Yield 2021 -
Capitalization 10 505 M 10 505 M -
EV / Sales 2021 3,73x
EV / Sales 2022 3,41x
Nbr of Employees 21 600
Free-Float 95,6%
Chart BAUSCH HEALTH COMPANIES INC.
Duration : Period :
Bausch Health Companies Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAUSCH HEALTH COMPANIES INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 34,88 $
Last Close Price 29,31 $
Spread / Highest target 87,6%
Spread / Average Target 19,0%
Spread / Lowest Target -31,8%
EPS Revisions
Managers and Directors
NameTitle
Joseph C. Papa Chairman & Chief Executive Officer
Thomas J. Appio President & Co-Head-Bausch Lomb International
Sam Eldessouky CFO, Chief Accounting Officer, SVP & Controller
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BAUSCH HEALTH COMPANIES INC.40.91%10 505
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795